Granules India acquires Swiss Senn Chemicals to foray into peptide and CDMO business
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Branded formulation business continues to perform well across domestic and export markets
The company remains focused on strengthening its direct retail presence and expanding its reach to more customers across India.
PAT after MI is Rs. 41 crore which is 162% increase
Hyper-automated AI is a unified framework combining AI, ML, RPA, and NLQ to streamline data extraction, quality management, transformation, and actionable insights - all on a single platform
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
Acquisition expands high-value medical platform
This strategic move aims to address the increasing global demand for biologics, enhancing ProBioGen's ability to support partners from cell line development t
Inaugurates new facilities to further NIMHANS’ mission of delivering cutting-edge care in mental health and neurosciences
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
Subscribe To Our Newsletter & Stay Updated